Port-Wine Stain clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Light Dose in Subjects With PWB Treated With Hemoporfin PDT
open to eligible people ages 18-75
This is a multi-center, randomized, double-blind, vehicle-controlled, and sequential group Phase 2 study. Eligible subjects aged 18 to 75 years old with PWB will receive Hemoporfin PDT or vehicle PDT in 8-week cycles at fixed drug dose (5 mg/kg) and different light fluence.
Irvine, California and other locations
Our lead scientists for Port-Wine Stain research studies include Kristen M. Kelly.
Last updated: